DRUG · Mapped RxNorm record
Ixabepilone
Normalized identity: ixabepiloneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
NCT00741988
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Bevacizumab
Normalized identity: bevacizumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedIxabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
IxabepiloneDRUG · verified · RxNorm: ixabepilone
CarboplatinDRUG · verified · RxNorm: carboplatin
BevacizumabDRUG · verified · RxNorm: bevacizumab
Sponsors & collaborators
SCRI Development Innovations, LLClead sponsor
Bristol-Myers Squibbcollaborator
Genentech, Inc.collaborator
Mapped research locations
NashvilleTennessee, United States1CincinnatiOhio, United States1BethesdaMaryland, United States1LouisvilleKentucky, United States1Kansas CityMissouri, United States1GainesvilleFlorida, United States1SpartanburgSouth Carolina, United States1Grand RapidsMichigan, United States1Fort MyersFlorida, United States1ColumbiaSouth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00741988 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.